Search

everythinglearnresearchcommunity

for

Search:↓

The treatment improved acne, seborrhoea, and hirsutism, with some side effects like spotting and nervousness.

Three specific 4-azasteroid-2-oximes showed strong enzyme inhibition, but less than finasteride.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

A woman's severe male hormone excess was caused by a small, hard-to-find ovarian tumor.

Two teenage boys lost hair after taking a drug for growth, which was not a known side effect for kids.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

A rare ovarian tumor was diagnosed in a woman from North Brazil, and surgery is the preferred treatment.

A woman's severe hirsutism was caused by Leydig cell tumors in her ovaries, which improved after surgery.

Chemoprevention can significantly lower cancer risks and needs more research and collaboration.

ROR-alpha may increase the growth of certain breast cancer cells by boosting aromatase, which could affect breast cancer prognosis.

The higher dose supplement was more effective in treating female hair loss.

Crisaborole may help regrow hair in children with alopecia areata.

Ocrelizumab may cause delayed hair loss in some patients.

Ritlecitinib can help about 14,000 people with severe hair loss.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

A new treatment using nanoliposomes can improve hair regrowth in androgenetic alopecia.

Leydig cell tumors in the ovary can cause high testosterone and male traits in postmenopausal women but are treatable with surgery.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

BRL 7660, once studied for male contraception, showed promise as an acne treatment but was not developed further due to competing drugs.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

A rare benign ovarian tumor was found in a pregnant woman, but both mother and baby remained healthy.

The new synthetic retinoid RO 13-6298 effectively treated severe psoriasis at low doses with manageable side effects.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Surgery successfully treated a hidden ovarian tumor causing hair loss and excess hair growth in a postmenopausal woman.

Hormone-replacement therapy improved a woman's skin condition known as lymphomatoid papulosis.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.